Advertisement

Impact of Comprehensive Health Insurance on Quality of Life in Low-Income Hispanic Men with Prostate Cancer

Published:November 15, 2022DOI:https://doi.org/10.1016/j.urology.2022.11.001

      Abstract

      Objective

      To evaluate the effect of the transition from IMPACT, a disease-focused treatment program, to comprehensive health insurance under Medicaid through the Affordable Care Act (ACA) on general and prostate cancer-specific quality of life (QoL) on a cohort of previously uninsured low-income men. We hypothesize that general QoL would improve and prostate cancer-specific QoL would remain the same after the transition to comprehensive health insurance.

      Methods

      We assessed and compared general QoL using the RAND SF-12v2™ (12-Item Short Form Survey, version 2) and prostate cancer-specific QoL using the UCLA PCI (Prostate Cancer Index) one year before, at, and one year after the transition between 30 men who transitioned to comprehensive insurance (newly insured/Medicaid group) and 54 men who remained in the prostate cancer program (uninsured/IMPACT group). We assessed the independent effects of Medicaid coverage on QoL outcomes using repeated-measures regression.

      Results

      Our cohort was composed primarily of Hispanic men (82%). At transition, patient demographics and clinical characteristics were similar between the groups. General and prostate cancer-specific QoL did not differ between the groups and remained stable over time, Radical prostatectomy as primary treatment and shorter time since treatment were associated with worse urinary and sexual function across both groups and over all three time points.

      Conclusions

      Those who transitioned to full-scope insurance and those who remained in the free prostate cancer-focused treatment program had stable general and prostate cancer-specific QoL. High-touch navigation aspects of a disease-focused program may have contributed to stability in outcomes.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Urology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      REFERENCES

        • Keegan KA
        • Penson DF.
        The Patient Protection and Affordable Care Act: the impact on urologic cancer care.
        Urol Oncol. 2013; 31: 980-984
        • Nathan NH
        • Bakhsheshian J
        • Ding L
        • Mack WJ
        • Attenello FJ.
        Evaluating Medicaid Expansion Benefits for Patients with Cancer: National Cancer Database Analysis and Systematic Review.
        J Cancer Policy. 2021; 29
        • Siegel RL
        • Miller KD
        • Fuchs HE
        • Jemal A.
        Cancer statistics, 2022.
        CA Cancer J Clin. 2022; 72: 7-33
        • Michel KF
        • Spaulding A
        • Jemal A
        • Yabroff KR
        • Lee DJ
        • Han X.
        Associations of Medicaid Expansion With Insurance Coverage, Stage at Diagnosis, and Treatment Among Patients With Genitourinary Malignant Neoplasms.
        JAMA Netw Open. 2021; 4e217051
        • Zhao J
        • Mao Z
        • Fedewa SA
        • et al.
        The Affordable Care Act and access to care across the cancer control continuum: A review at 10 years.
        CA Cancer J Clin. 2020; 70: 165-181
        • Mahal BA
        • Aizer AA
        • Ziehr DR
        • et al.
        The association between insurance status and prostate cancer outcomes: implications for the Affordable Care Act.
        Prostate Cancer Prostatic Dis. 2014; 17: 273-279
        • Zavala MW
        • Maliski SL
        • Kwan L
        • Miller DC
        • Fink A
        • Litwin MS.
        Longitudinal quality of life in low-income men in a state-funded prostate cancer treatment program.
        J Health Care Poor Underserved. 2008; 19: 200-214
        • Shusted CS
        • Barta JA
        • Lake M
        • et al.
        The Case for Patient Navigation in Lung Cancer Screening in Vulnerable Populations: A Systematic Review.
        Popul Health Manag. 2019; 22: 347-361
        • Nabhani JA
        • Kuang R
        • Liu H
        • Kwan L
        • Litwin MS.
        Health Changes in Low Income Men Transitioning from a State Funded Prostate Cancer Program to Comprehensive Insurance.
        J Urol. 2018; 200: 74-81
        • Ware Jr., J
        • Kosinski M
        • Keller SD
        A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity.
        Med Care. 1996; 34: 220-233
        • Litwin MS
        • Hays RD
        • Fink A
        • Ganz PA
        • Leake B
        • Brook RH.
        The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure.
        Med Care. 1998; 36: 1002-1012
      1. Henderson A RW, Finegold K. The Affordable Care Act and Latinos: Assistant Secretary for Planning and Evaluation (ASPE), 2012.

      2. Doty M.M. RPW, Collins S.R. Catching Up: Latino Health Coverage Gains and Challenges Under the Affordable Care Act: The Commonwealth Fund, 2014.

        • Barnett ML
        • Clark KL
        • Sommers BD.
        State Policies And Enrollees' Experiences In Medicaid: Evidence From A New National Survey.
        Health Aff (Millwood). 2018; 37: 1647-1655
        • Figueroa JF
        • Reimold KE
        • Zheng J
        • Orav EJ.
        Differences in Patient Experience Between Hispanic and Non-Hispanic White Patients Across U.S. Hospitals.
        J Healthc Qual. 2018; 40: 292-300
        • Mandelblatt JS
        • Yabroff KR
        • Kerner JF.
        Equitable access to cancer services: A review of barriers to quality care.
        Cancer. 1999; 86: 2378-2390
        • Smith AW
        • Bellizzi KM
        • Keegan TH
        • et al.
        Health-related quality of life of adolescent and young adult patients with cancer in the United States: the Adolescent and Young Adult Health Outcomes and Patient Experience study.
        J Clin Oncol. 2013; 31: 2136-2145
        • Ermer T
        • Walters SL
        • Canavan ME
        • et al.
        Understanding the Implications of Medicaid Expansion for Cancer Care in the US: A Review.
        JAMA Oncol. 2022; 8: 139-148
        • Hong YR
        • Jo A
        • Mainous 3rd, AG
        Up-to-Date on Preventive Care Services Under Affordable Care Act: A Trend Analysis From MEPS 2007-2014.
        Med Care. 2017; 55: 771-780
        • Abdus S.
        Trends in Differences Across Subgroups of Adults in Preventive Services Utilization.
        Med Care. 2021; 59: 1059-1066
        • Bloodworth R
        • Chen J
        • Mortensen K.
        Variation of preventive service utilization by state Medicaid coverage, cost-sharing, and Medicaid expansion status.
        Prev Med. 2018; 115: 97-103
        • Hing E
        • Decker S
        • Jamoom E.
        Acceptance of new patients with public and private insurance by office-based physicians: United States.
        NCHS Data Brief. 2013; 2015: 1-8
        • Selden TM
        • Lipton BJ
        • Decker SL.
        Medicaid Expansion And Marketplace Eligibility Both Increased Coverage, With Trade-Offs In Access.
        Affordability. Health Aff (Millwood). 2017; 36: 2069-2077
        • Miller S
        • Wherry LR.
        Health and Access to Care during the First 2 Years of the ACA Medicaid Expansions.
        N Engl J Med. 2017; 376: 947-956
        • Miller DC
        • Gelberg L
        • Kwan L
        • et al.
        Racial disparities in access to care for men in a public assistance program for prostate cancer.
        J Community Health. 2008; 33: 318-335
        • Saigal CS
        • Wessells H
        • Pace J
        • Schonlau M
        • Wilt TJ
        Urologic Diseases in America P. Predictors and prevalence of erectile dysfunction in a racially diverse population.
        Arch Intern Med. 2006; 166: 207-212
        • Donovan JL
        • Hamdy FC
        • Lane JA
        • et al.
        Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer.
        N Engl J Med. 2016; 375: 1425-1437
        • Resnick MJ
        • Koyama T
        • Fan KH
        • et al.
        Long-term functional outcomes after treatment for localized prostate cancer.
        N Engl J Med. 2013; 368: 436-445
        • Wilt TJ
        • Brawer MK
        • Jones KM
        • et al.
        Radical prostatectomy versus observation for localized prostate cancer.
        N Engl J Med. 2012; 367: 203-213
        • Skolarus TA
        • Wolf AM
        • Erb NL
        • et al.
        American Cancer Society prostate cancer survivorship care guidelines.
        CA Cancer J Clin. 2014; 64: 225-249